For future access to innovative technologies/
novel therapeutic drug targets and collaboration
with early stage startup companies

NewsList

List

Mission

Ono Venture Investment, Inc. (OVI) is the corporate venture capital arm of Ono Pharmaceutical Co.,Ltd. ,
an R&D-oriented pharmaceutical company succeeded in delivery of “First in class”
medicines to patients such as OPDIVO® (nivolumab).

Learn More

Priority Areas

  • Oncology

  • Immunology

  • Neurology

  • Specialty

To fulfill our mission as a Corporate Venture Capital, OVI prioritizes to make investment in novel startups possessing products and
platforms potentially with high synergy to R&D of our parent company, Ono Pharmaceutical Co.,Ltd. .

Learn More
Ono Pharmaceutical Co., Ltd

Ono Pharmaceutical Co., Ltd., headquartered in Osaka, is an R&D-oriented pharmaceutical company committed to creating innovative medicines in specific areas.

Ono Pharmaceutical Co.,Ltd. WebSite

Ono has another CVC, Ono Digital health Investment,GK("Ono Digital health").
Ono Digital health invests in start-up/venture companies engaged in healthcare-related business.
They view healthcare as a condition in which the degree of satisfaction with life is high physically and socially, therefore they invest in areas that are not restricted to Ono Pharmaceutical Co,Ltd.'s R&D domain.

Ono Digital health Investment,GK website